Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Indolinone. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110577483A enables water-based synthesis of indolinone derivatives. This breakthrough offers significant supply chain stability and cost reduction advantages for global pharmaceutical manufacturing partners.
Discover the advanced one-pot tandem synthesis of oxindoles from patent CN103304468A. Achieve cost reduction in pharmaceutical intermediates manufacturing with high purity.
Novel Pd-catalyzed multicomponent route for indolinone-imidazole scaffolds offering cost reduction and scalable manufacturing for pharma intermediates.
Patent CN110372774B reveals a novel MOF-Cu catalyzed Ugi reaction for isoindolinone dipeptides. Discover cost-effective agrochemical intermediate manufacturing solutions.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN115353511A details a novel multi-component Pd-catalyzed method for synthesizing carbonyl-bridged biheterocycles, offering safer conditions and cost reduction in API manufacturing.
Novel Pd-catalyzed multicomponent method for carbonyl-bridged biheterocycles. Efficient, scalable, CO-free process for pharma intermediates.
Patent CN115353511A discloses a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering safer conditions and high yields for API manufacturing.
Novel Pd-catalyzed multi-component method for high-purity intermediates. Efficient, scalable, CO-free process reduces manufacturing costs significantly.
Patent CN113735756A details a novel Rh-catalyzed C-H activation method for chiral 3,3-disubstituted isoindolinones, offering high enantioselectivity and streamlined manufacturing for pharmaceutical intermediates.
Patent CN115353511A details a safe, one-pot Pd-catalyzed carbonylation for synthesizing indolinone-imidazole hybrids, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN113735756A details a high-yield Rh-catalyzed method for chiral 3,3-disubstituted isoindolinones, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN113980028A reveals a mild organocatalytic route for chiral spiro indolones. Discover cost-effective manufacturing and high stereoselectivity for API intermediates.
Patent CN108440384A reveals a mild copper-catalyzed method for isoindolinone derivatives, offering cost reduction and scalable supply chain solutions for pharmaceutical manufacturing.
Novel one-pot Rh(III) catalysis for nitrogen heterocycles. High yield, mild conditions, cost-effective supply chain solution.
Patent CN113735756B reveals high-yield rhodium catalysis for chiral isoindolinones. Offers cost reduction and supply chain reliability for pharmaceutical intermediate manufacturing.
Novel Pd-catalyzed multicomponent route avoids toxic CO gas, offering high efficiency and scalability for pharmaceutical intermediates.
Patent CN115353511A details a novel multi-component Pd-catalyzed method for synthesizing carbonyl-bridged biheterocycles, offering cost reduction and scalability for pharmaceutical intermediates.
Patent CN115353511A details a novel palladium-catalyzed carbonylation cascade for synthesizing indolinone-imidazole hybrids, offering safer, scalable routes for pharmaceutical intermediates.
Patent CN115353511A details a novel Pd-catalyzed multicomponent synthesis for carbonyl-bridged biheterocycles, offering cost reduction in API manufacturing and scalable routes.